Elizabeth Bilsborough
Nurse Practitioner · Harris, TXNPI 1922734417
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (36.5%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Eisai Inc. accounts for 90.6% of it on its own, with 16 other manufacturers making up the rest. Among nurse practitioner clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 145 payments — averaging $235.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$31K
- Medtronic$2K
- AbbVie$139
- UCB, Inc.$130
- Octapharma USA, Inc.$103
- Cerapedics Inc.$93
- plus $428 from 11 others
What the payments were for
- Consulting fees$7,90023%
- Speaking & faculty fees$12,46536%
- Travel & lodging$10,42631%
- Food & beverage$3,34410%
- Education$450%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 78 | $30,981 |
| Medtronic | 34 | $2,305 |
| AbbVie | 6 | $139 |
| UCB, Inc. | 5 | $130 |
| Octapharma USA, Inc. | 1 | $103 |
| Cerapedics Inc. | 3 | $93 |
| Acadia Pharmaceuticals Inc | 4 | $65 |
| Otter Pharmaceuticals, LLC | 2 | $61 |
| EMD Serono, Inc. | 3 | $61 |
| Axsome Therapeutics, Inc. | 2 | $59 |
| Teva Pharmaceuticals USA, Inc. | 1 | $43 |
| Argenx US, Inc. | 1 | $29 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $27 |
| Sanofi | 1 | $24 |
| CSL Behring | 1 | $23 |
| Novartis | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Leqembi$29,992
- STEALTHSTATION S8 PLATFORM$1,070
- ASCENDA$156
- STRATA$125
- Duet$121
- SYNCHROMEDII$107
- PANZYGA$103
How this compares
$34,180 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rivastigmine | 12 | $1,359 |
| Memantine Hcl | 33 | $1,125 |
| Donepezil Hcl | 65 | $822 |
| Escitalopram Oxalate | 20 | $134 |
| Gabapentin | 13 | $129 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 27 | $115 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Harris
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Corrie BerkSan Antonio$155K
- Samantha OnealDallas$133K
- Onna FeuchterSouthlake$108K
- Stephanie AgrellaRound Rock$102K
- Sue RankinAmarillo$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.